These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8254818)

  • 1. Antitumoral effects of liarozole in androgen-dependent and independent R3327-Dunning prostate adenocarcinomas.
    Dijkman GA; Van Moorselaar RJ; Van Ginckel R; Van Stratum P; Wouters L; Debruyne FM; Schalken JA; de Coster R
    J Urol; 1994 Jan; 151(1):217-22. PubMed ID: 8254818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
    Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liarozole, an antitumor drug, modulates cytokeratin expression in the Dunning AT-6sq prostatic carcinoma through in situ accumulation of all-trans-retinoic acid.
    Smets G; Van Ginckel R; Daneels G; Moeremans M; Van Wauwe J; Coene MC; Ramaekers FC; Schalken JA; Borgers M; De Coster R
    Prostate; 1995 Sep; 27(3):129-40. PubMed ID: 7567691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P450-dependent enzymes as targets for prostate cancer therapy.
    De Coster R; Wouters W; Bruynseels J
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):133-43. PubMed ID: 8603034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumoral effects of R 75251 on the growth of transplantable R3327 prostatic adenocarcinoma in rats.
    Van Ginckel R; De Coster R; Wouters W; Vanherck W; van der Veer R; Goeminne N; Jagers E; Van Cauteren H; Wouters L; Distelmans W
    Prostate; 1990; 16(4):313-23. PubMed ID: 2371176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of androgen receptor levels to androgen responsiveness in the Dunning R3327 rat prostate tumor sublines.
    Diamond DA; Barrack ER
    J Urol; 1984 Oct; 132(4):821-7. PubMed ID: 6471235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental studies with liarozole (R 75,251): an antitumoral agent which inhibits retinoic acid breakdown.
    De Coster R; Wouters W; Van Ginckel R; End D; Krekels M; Coene MC; Bowden C
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):197-201. PubMed ID: 1525060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of olfactory bulbectomy, melatonin, and/or pinealectomy on three sublines of the Dunning R3327 rat prostatic adenocarcinoma.
    Toma JG; Amerongen HM; Hennes SC; O'Brien MG; McBlain WA; Buzzell GR
    J Pineal Res; 1987; 4(3):321-38. PubMed ID: 3625464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J; Reile H; Halmos G; Groot K; Schally AV
    Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of active immunization against luteinizing hormone-releasing hormone on the androgen-sensitive Dunning R3327-PAP and androgen-independent Dunning R3327-AT2.1 prostate cancer sublines.
    Fuerst J; Fiebiger E; Jungwirth A; Mack D; Talwar PG; Frick J; Rovan E
    Prostate; 1997 Jul; 32(2):77-84. PubMed ID: 9215394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
    Sylvester PW; Ip MM
    Prostate; 1987; 10(1):57-67. PubMed ID: 3822918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-dehydro-melengestrol acetate inhibits the growth and protein kinase C activity of androgen-independent Dunning rat prostatic tumors.
    Battistone MJ; Padilla GM; Petrow V
    Cancer Chemother Pharmacol; 1993; 31(5):407-11. PubMed ID: 8431975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melengestrol acetate and megestrol acetate are prostatic tumor inhibiting agents.
    Padilla GM; Yacullo RC; Padilla JJ; Payne B; Petrow V
    Biochem Cell Biol; 1990 Oct; 68(10):1181-8. PubMed ID: 2268413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A; Tomic R
    J Cancer Res Clin Oncol; 1992; 118(1):30-4. PubMed ID: 1729258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
    Brändström A; Westin P; Bergh A; Cajander S; Damber JE
    Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.
    Ip MM; Milholland RJ; Rosen F
    Cancer Res; 1980 Jul; 40(7):2188-93. PubMed ID: 7388787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of androgen-primed chemotherapy in the Dunning R3327 G model of prostatic cancer.
    English HF; Heitjan DF; Lancaster S; Santen RJ
    Cancer Res; 1991 Apr; 51(7):1760-5. PubMed ID: 2004359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dunning R3327-G prostate carcinoma of the rat: an appropriate model for drug evaluation.
    Kager M; Spruss T; Schneider MR; von Angerer E
    J Cancer Res Clin Oncol; 1992; 118(5):334-8. PubMed ID: 1583064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liarozole.
    Bryson HM; Wagstaff AJ
    Drugs Aging; 1996 Dec; 9(6):478-84; discussion 485. PubMed ID: 8972247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inhibitory effect of TZP-4238 on the growth of androgen-sensitive rat prostatic tumor (Dunning R3327).
    Ichikawa T; Akimoto S; Shimazaki J
    Endocr J; 1993 Aug; 40(4):425-30. PubMed ID: 7522799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.